FI963054A - Förfarande för framställning av HIV proteas inhibitorer - Google Patents
Förfarande för framställning av HIV proteas inhibitorer Download PDFInfo
- Publication number
- FI963054A FI963054A FI963054A FI963054A FI963054A FI 963054 A FI963054 A FI 963054A FI 963054 A FI963054 A FI 963054A FI 963054 A FI963054 A FI 963054A FI 963054 A FI963054 A FI 963054A
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- hiv protease
- piperazine
- protease inhibitors
- optically pure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Cephalosporin Compounds (AREA)
- Catalysts (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19291694A | 1994-02-04 | 1994-02-04 | |
| US19291694 | 1994-02-04 | ||
| PCT/US1995/001232 WO1995021162A1 (en) | 1994-02-04 | 1995-01-30 | Process for making hiv protease inhibitors |
| US9501232 | 1995-01-30 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI963054A true FI963054A (sv) | 1996-08-01 |
| FI963054A0 FI963054A0 (sv) | 1996-08-01 |
| FI112218B FI112218B (sv) | 2003-11-14 |
Family
ID=22711555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI963054A FI112218B (sv) | 1994-02-04 | 1996-08-01 | Förfarande för framställning av ett optiskt rent eller anrikat piperazin-2-tert-butylkarboxamidsubstrat |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5663341A (sv) |
| EP (1) | EP0741712B1 (sv) |
| JP (1) | JPH09508628A (sv) |
| KR (1) | KR100337579B1 (sv) |
| AT (1) | ATE206407T1 (sv) |
| AU (1) | AU691878B2 (sv) |
| BR (1) | BR9506727A (sv) |
| CA (1) | CA2180947A1 (sv) |
| CZ (1) | CZ291774B6 (sv) |
| DE (1) | DE69523038T2 (sv) |
| ES (1) | ES2161863T3 (sv) |
| FI (1) | FI112218B (sv) |
| HU (1) | HUT76303A (sv) |
| NZ (1) | NZ279734A (sv) |
| RO (1) | RO118292B1 (sv) |
| RU (1) | RU2135482C1 (sv) |
| SK (1) | SK281861B6 (sv) |
| TW (1) | TW472047B (sv) |
| UA (1) | UA46730C2 (sv) |
| WO (1) | WO1995021162A1 (sv) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL110255A (en) * | 1993-07-16 | 1998-12-06 | Merck & Co Inc | Creation and resolution of 2 tert-butylcarboxamidopiprazine |
| US5464788A (en) * | 1994-03-24 | 1995-11-07 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
| DE69527683T2 (de) * | 1994-04-22 | 2003-04-10 | Koei Chemical Co | Verfahren zur herstellung von optisch aktivem n-tert-butyl-2-piperazincarboxamidamid |
| DK0710652T3 (da) * | 1994-11-04 | 1998-09-28 | Yamakawa Chemical Ind | Fremgangsmåde til fremstilling af optisk aktive piperazinderivater og mellemprodukter til fremstillingen |
| JPH11500425A (ja) * | 1995-01-23 | 1999-01-12 | ロンザ アーゲー | １，４，５，６−テトラヒドロピラジン−２−カルボキサミドの製造方法 |
| US5618937A (en) * | 1995-03-15 | 1997-04-08 | Merck & Co., Inc. | Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide |
| US5612484A (en) * | 1995-05-18 | 1997-03-18 | Merck & Co., Inc. | Process for making HIV protease inhibitors |
| DE19536658C2 (de) * | 1995-09-30 | 1998-02-19 | Degussa | Verfahren zur kontinuierlichen Herstellung von basischen, cyclischen, optisch aktiven alpha-Aminosäuren |
| CA2201218C (en) * | 1996-04-23 | 2004-09-28 | Rudolf Fuchs | Process for the preparation of optically active piperazine-2-carboxylic acid derivatives |
| EP1592389B1 (en) * | 2003-02-14 | 2009-04-22 | Laboratoires Serono SA | Piperazine-2-carboxamide derivatives |
| GB0314260D0 (en) * | 2003-06-19 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB604185A (en) * | 1940-08-08 | 1948-06-30 | Arthur Mandl | Improvements in electric rectifier systems used in power or control systems such as for follow-up systems |
| US3692775A (en) * | 1969-03-17 | 1972-09-19 | Allied Chem | Racemization of d-or l-{60 -amino-caprolactam in the presence of metal ions |
| US3852351A (en) * | 1972-10-02 | 1974-12-03 | Fmc Corp | Chlorination of acetoacetamides |
| JPH01117869A (ja) * | 1987-10-30 | 1989-05-10 | Hokuriku Seiyaku Co Ltd | ２−アミノメチルピペラジン誘導体 |
| CA1340588C (en) * | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
| US5413999A (en) * | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| EP0541168B1 (en) * | 1991-11-08 | 1998-03-11 | Merck & Co. Inc. | HIV protease inhibitors useful for the treatment of aids |
| MX9308016A (es) * | 1992-12-22 | 1994-08-31 | Lilly Co Eli | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. |
-
1995
- 1995-01-27 TW TW084100727A patent/TW472047B/zh not_active IP Right Cessation
- 1995-01-30 BR BR9506727A patent/BR9506727A/pt active Search and Examination
- 1995-01-30 EP EP95908747A patent/EP0741712B1/en not_active Expired - Lifetime
- 1995-01-30 CZ CZ19962272A patent/CZ291774B6/cs not_active IP Right Cessation
- 1995-01-30 ES ES95908747T patent/ES2161863T3/es not_active Expired - Lifetime
- 1995-01-30 AT AT95908747T patent/ATE206407T1/de not_active IP Right Cessation
- 1995-01-30 RU RU96117468/04A patent/RU2135482C1/ru not_active IP Right Cessation
- 1995-01-30 KR KR1019960704219A patent/KR100337579B1/ko not_active IP Right Cessation
- 1995-01-30 WO PCT/US1995/001232 patent/WO1995021162A1/en active Search and Examination
- 1995-01-30 DE DE69523038T patent/DE69523038T2/de not_active Expired - Fee Related
- 1995-01-30 CA CA002180947A patent/CA2180947A1/en not_active Abandoned
- 1995-01-30 NZ NZ279734A patent/NZ279734A/en unknown
- 1995-01-30 HU HU9602143A patent/HUT76303A/hu unknown
- 1995-01-30 SK SK1006-96A patent/SK281861B6/sk unknown
- 1995-01-30 AU AU16967/95A patent/AU691878B2/en not_active Ceased
- 1995-01-30 RO RO96-01576A patent/RO118292B1/ro unknown
- 1995-01-30 JP JP7520686A patent/JPH09508628A/ja not_active Withdrawn
- 1995-01-30 UA UA96093433A patent/UA46730C2/uk unknown
- 1995-06-07 US US08/487,903 patent/US5663341A/en not_active Expired - Fee Related
-
1996
- 1996-08-01 FI FI963054A patent/FI112218B/sv active
Also Published As
| Publication number | Publication date |
|---|---|
| NZ279734A (en) | 1998-05-27 |
| DE69523038T2 (de) | 2002-06-06 |
| MX9603218A (es) | 1997-07-31 |
| RO118292B1 (ro) | 2003-04-30 |
| EP0741712B1 (en) | 2001-10-04 |
| BR9506727A (pt) | 1997-09-23 |
| CA2180947A1 (en) | 1995-08-10 |
| KR100337579B1 (ko) | 2002-11-13 |
| CZ227296A3 (en) | 1997-01-15 |
| US5663341A (en) | 1997-09-02 |
| AU691878B2 (en) | 1998-05-28 |
| AU1696795A (en) | 1995-08-21 |
| EP0741712A1 (en) | 1996-11-13 |
| ATE206407T1 (de) | 2001-10-15 |
| HU9602143D0 (en) | 1996-09-30 |
| TW472047B (en) | 2002-01-11 |
| CZ291774B6 (cs) | 2003-05-14 |
| JPH09508628A (ja) | 1997-09-02 |
| ES2161863T3 (es) | 2001-12-16 |
| SK100696A3 (en) | 1997-03-05 |
| UA46730C2 (uk) | 2002-06-17 |
| FI963054A0 (sv) | 1996-08-01 |
| RU2135482C1 (ru) | 1999-08-27 |
| SK281861B6 (sk) | 2001-08-06 |
| HUT76303A (en) | 1997-07-28 |
| FI112218B (sv) | 2003-11-14 |
| WO1995021162A1 (en) | 1995-08-10 |
| DE69523038D1 (de) | 2001-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL291470A1 (en) | Method of obtaining novel urea derivatives | |
| DK0997459T3 (da) | Mellemprodukter til fremstilling af retrovirale protease-hæmmere | |
| FI963054A (sv) | Förfarande för framställning av HIV proteas inhibitorer | |
| EA200000826A1 (ru) | Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы | |
| NO931482D0 (no) | Farmasoeytiske sammensetninger inneholdende quinolin- og quinazolinderivater og nye forbindelser for disse | |
| RU92016490A (ru) | Новые 2-сахаринилметил(арил и арокси)ацетаты, применимые в качестве ингибиторов протеолитических ферментов, их композиции и способ их применения | |
| DZ1724A1 (fr) | Nouvelles azétidinones substituées comme agents anti-inflammatoires et anti-dégénérescence. | |
| WO1995002584A3 (en) | Process for making hiv protease inhibitors | |
| DE69432176T2 (de) | Verfahren zur herstellung von hiv protease inhibitoren | |
| BG105825A (en) | Process for preparing alendronic acid | |
| ES2147499A1 (es) | Derivados de acidos carboxilicos, metodo para su elaboracion y agentes terapeuticos que contienen estos compuestos. | |
| DE69821763D1 (de) | Verfahren zur herstellung von 2-alkylthio-substituierten benzoesäurederivaten | |
| TH14727A (th) | ซับสทิทิวเต็ดอะเซ็ททิดิโนนชนิดใหม่ที่เป็นสารต้านการอักเสบและสารต้านการเสื่อมโทรม | |
| FI944967A (sv) | Förfaranden för framställning av sackarinderivat användbara som inhibitorer för proteolytiskt enzym och mellanprodukter därav | |
| TH52453A (th) | รูปแบบซูโดโพลีมอร์ฟิกชนิดใหม่ของ 2-[2-[4-[บิส-(4-ฟลูออโรฟีนิล) เมธิล]-1-พิเพอราซินิล]เอธอกซี]อะซีติกแอซิดไดไฮโดรคลอไรด์ |